Search results
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 21 hours agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 5 hours ago"The major safety concerns would likely have precluded...Street numbers for Sarepta," RBC Capital ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 3 days agoThe Zacks Value ...and so on), is pretty helpful in identifying whether a stock is overvalued,...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 6 hours agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 hours agoCiti thinks this development has been reflected in WuXi AppTec’s share-price surge on Wednesday but “second-day profit taking” could weigh on the...
Indexes Mixed; Warren Buffett Stock Could Exit Nasdaq 100; Tesla Climbs On Elon Musk's Pay Vote...
Investor's Business Daily· 1 hour agoThe Dow Jones fell slightly but other indexes rose to record highs after inflation data. Tesla...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 5 days agoAnd right now, it yields 5.4%. That's even as the stock has soared more than 40% this year. Organon...
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 6 days agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 2 days agoWith its stock price fast approaching $1000 per share, drugmaker Eli lilly is poised for a forward ...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 6 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...